Noninvasive Brain Stimulation Protects Cognitive Impairment in i.c.v. STZ-Injected Rats: Role of Adult Neurogenesis
Kumar A, Roy A, Karaddi V, Jain S, Katyal J, Gupta YK · 2025
Noninvasive extremely low-frequency magnetic field stimulation may protect against cognitive impairment in an animal model of Alzheimer's disease by promoting adult neurogenesis and reducing neuroinflammation.
Plain English Summary
This study investigated whether extremely low-frequency magnetic field stimulation (17.96 μT, 50 Hz, 2 hours daily for 2 weeks) could improve cognitive function in rats with streptozotocin-induced Alzheimer's-like dementia. The researchers found that the magnetic field stimulation improved spatial and reference memory, stimulated adult neurogenesis in the brain, reduced oxidative stress, and provided neuroprotection in key brain regions including the hippocampus and prefrontal cortex.
Why This Matters
Adult neurogenesis in the hippocampus is known to decline with age and in neurodegenerative diseases, making it a potential therapeutic target for dementia. This study proposes a non-pharmacological mechanism through which magnetic field stimulation could influence neural stem cell activity, though further research would be needed to determine translational relevance to human disease.
Exposure Information
Specific exposure levels were not quantified in this study.
Watch: Video About This Study
Show BibTeX
@article{noninvasive_brain_stimulation_protects_cognitive_impairment_in_icv_stz_injected_rats_role_of_adult_neurogenesis_ce4447,
author = {Kumar A and Roy A and Karaddi V and Jain S and Katyal J and Gupta YK},
title = {Noninvasive Brain Stimulation Protects Cognitive Impairment in i.c.v. STZ-Injected Rats: Role of Adult Neurogenesis},
year = {2025},
doi = {10.1038/s41588-025-02153-x},
}